Brent Ragans is the U.S. President of Ferring Pharmaceuticals, a privately-owned, biopharma company that focuses on developing life-changing innovations that help people live better lives. In the United States, Ferring is a leader in reproductive medicine, uro-oncology and in specialty areas within orthopaedics, and gastroenterology.

Brent’s vision for serving patients is grounded in Ferring’s 70-year commitment to science, research and the relentless pursuit of therapies that help people build families, stay healthy and fight disease.

Becoming president in June 2020, Brent focused Ferring U.S. in the therapy areas where it makes the greatest positive impact for patients. Previously as U.S. Chief Commercial Officer, Brent led commercial strategy and operations as the company introduced new products and doubled its sales.